Brand drug manufacturers use a variety of strategies to extend the exclusivity of their drugs beyond the end of their original 20-year exclusivity period. They use “patent thickets” as an extension tool by filing multiple additional patents on the same
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today following remarks by Food and Drug Administration Commissioner Scott Gottlieb: “Manufacturers have chosen to negotiate price concessions with pharmacy benefit managers (PBMs) using rebates, which are
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
JC Scott (00:08): Welcome to the Pharmacy Benefit, a podcast where we talk about issues impacting patients, consumers, and affordable access to prescription drugs and better healthcare through the work being done by pharmacy benefit managers or PBMs. I’m
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a Medicare Part D report released today by the Office of Inspector (OIG), U.S. Department of Health and Human Services (HHS): “This report finally debunks the myth
©2024 PCMA. All Rights Reserved.
